Prior to the issuance of a cease and desist order under this chapter, the Division shall make a written finding of fact based on such investigation that the drug, medicine, compound or device so investigated has been found to be of no value in the diagnosis, treatment or cure of cancer.
(Added to NRS by 1960, 64; A 1977, 1222)